title: U.S. biomedical policy. NCI head to fill in at FDA after Crawford resignation.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Couzin
authors.forename: Jocelyn
authors.initials: J
authors.lastname: Kaiser
mesh_terms: D000970:Antineoplastic Agents; D017277:Drug Approval; D049674:History, 21st Century; D006801:Humans; D009316:National Institutes of Health (U.S.) / Q000458:organization & administration*; D009369:Neoplasms / Q000188:drug therapy / Q000401:mortality; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration*
chemical_list: D000970:Antineoplastic Agents